MicroRNA network associated with chronic lymphocytic leukemia

No Pathway Network information available for MicroRNA network associated with chronic lymphocytic leukemia

Pathways in the MicroRNA network associated with chronic lymphocytic leukemia SuperPath

#	Name	Source	Genes
1	MicroRNA network associated with chronic lymphocytic leukemia	WikiPathways	ADAMTSL4-AS1 BCL2 MIR15A MIR16-1 TP53 ZAP70 (see all 6) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	ZAP70	Zeta Chain Of T Cell Receptor Associated Protein Kinase 70	Protein Coding	1
2	TP53	Tumor Protein P53	Protein Coding	1
3	BCL2	BCL2 Apoptosis Regulator	Protein Coding	1
4	MIR16-1	MicroRNA 16-1	RNA Gene	1
5	MIR15A	MicroRNA 15a	RNA Gene	1
6	ADAMTSL4-AS1	ADAMTSL4 Antisense RNA 1	RNA Gene	1

Disorders associated with MicroRNA network associated with chronic lymphocytic leukemia SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Immunodeficiency 48	Enrichment	ZAP70	3.35
2	Bone marrow failure syndrome 5	Enrichment	TP53	3.35
3	Papilloma of choroid plexus	Enrichment	TP53	3.35
4	Basal cell carcinoma 7	Enrichment	TP53	3.35
5	Anaplastic thyroid carcinoma	Enrichment	TP53	3.35
6	Ductal carcinoma in situ	Enrichment	TP53	3.35
7	Autoimmune disease, multisystem, infantile-onset, 2	Enrichment	ZAP70	3.35
8	Thyroid gland undifferentiated carcinoma	Enrichment	TP53	3.35
9	Small-cell carcinoma of the ovary of hypercalcemic type	Enrichment	TP53	3.35
10	Diffuse pediatric-type high-grade glioma, h3-wildtype and idh-wildtype	Enrichment	TP53	3.35
11	Choroid plexus cancer	Enrichment	TP53	3.35
12	Pleomorphic xanthoastrocytoma	Enrichment	TP53	3.35
13	Zap70-related severe combined immunodeficiency	Enrichment	ZAP70	3.35
14	Adrenocortical carcinoma, hereditary	Enrichment	TP53	3.05
15	Cervical cancer	Enrichment	TP53	3.05
16	Lymphoma, hodgkin, classic	Enrichment	TP53	3.05
17	Intravascular large b-cell lymphoma	Enrichment	BCL2	3.05
18	Congenital fibrosarcoma	Enrichment	TP53	3.05
19	Li-fraumeni syndrome 1	Enrichment	TP53	3.05
20	Sarcoma	Enrichment	TP53	3.05
21	Cervix carcinoma	Enrichment	TP53	3.05
22	Hodgkin's lymphoma	Enrichment	TP53	3.05
23	Pleomorphic rhabdomyosarcoma	Enrichment	TP53	3.05
24	Osteogenic sarcoma	Enrichment	TP53	2.88
25	Nasopharyngeal carcinoma	Enrichment	TP53	2.88
26	High-grade b-cell lymphoma double-hit/triple-hit	Enrichment	BCL2	2.88
27	Atypical teratoid rhabdoid tumor	Enrichment	TP53	2.88
28	Anaplastic astrocytoma	Enrichment	TP53	2.88
29	Squamous cell carcinoma	Enrichment	TP53	2.88
30	Adenocarcinoma	Enrichment	TP53	2.88
31	Bone osteosarcoma	Enrichment	TP53	2.88
32	Small cell cancer of the lung	Enrichment	TP53	2.75
33	Thyroid cancer, nonmedullary, 1	Enrichment	TP53	2.75
34	Lung sarcomatoid carcinoma	Enrichment	TP53	2.75
35	Embryonal rhabdomyosarcoma	Enrichment	TP53	2.75
36	Rhabdomyosarcoma 2	Enrichment	TP53	2.66
37	Follicular lymphoma	Enrichment	BCL2	2.66
38	Lymphoma	Enrichment	TP53	2.66
39	Acute megakaryocytic leukemia	Enrichment	TP53	2.66
40	Li-fraumeni syndrome	Enrichment	TP53	2.58
41	Adrenocortical carcinoma	Enrichment	TP53	2.58
42	Breast adenocarcinoma	Enrichment	TP53	2.58
43	Esophageal cancer	Enrichment	TP53	2.51
44	Squamous cell carcinoma, head and neck	Enrichment	TP53	2.51
45	Essential thrombocythemia	Enrichment	TP53	2.51
46	Gallbladder cancer	Enrichment	TP53	2.51
47	B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)	Enrichment	TP53	2.51
48	Glioma susceptibility 1	Enrichment	TP53	2.45
49	Lymphoma, non-hodgkin, familial	Enrichment	TP53	2.45
50	Adult hepatocellular carcinoma	Enrichment	TP53	2.40
51	Primary hyperaldosteronism	Enrichment	TP53	2.40
52	Leukemia, chronic lymphocytic	Enrichment	TP53	2.35
53	Familial colorectal cancer	Enrichment	TP53	2.35
54	Myelodysplastic syndrome	Enrichment	TP53	2.31
55	Combined immunodeficiency	Enrichment	ZAP70	2.31
56	Combined t cell and b cell immunodeficiency	Enrichment	ZAP70	2.31
57	Combined t and b cell immunodeficiency	Enrichment	ZAP70	2.31
58	Lip and oral cavity carcinoma	Enrichment	TP53	2.28
59	Lung cancer susceptibility 3	Enrichment	TP53	2.21
60	Rhabdomyosarcoma	Enrichment	TP53	2.15
61	Gliosarcoma	Enrichment	TP53	2.15
62	Giant cell glioblastoma	Enrichment	TP53	2.13
63	Diffuse large b-cell lymphoma	Enrichment	TP53	2.08
64	Hepatoblastoma	Enrichment	TP53	2.03
65	Hepatocellular carcinoma	Enrichment	TP53	2.01
66	Diamond-blackfan anemia 1	Enrichment	TP53	1.99
67	Pancreatic cancer	Enrichment	TP53	1.96
68	Bladder cancer	Enrichment	TP53	1.89
69	Prostate cancer	Enrichment	TP53	1.89
70	Severe combined immunodeficiency	Enrichment	ZAP70	1.84
71	Diamond-blackfan anemia	Enrichment	TP53	1.80
72	Leukemia, acute myeloid	Enrichment	TP53	1.76
73	Gastric cancer	Enrichment	TP53	1.72
74	Hereditary breast carcinoma	Enrichment	TP53	1.71
75	Hereditary breast ovarian cancer syndrome	Enrichment	TP53	1.62
76	Myeloma, multiple	Enrichment	TP53	1.61
77	Breast cancer	Enrichment	TP53	1.49
78	Colorectal cancer	Enrichment	TP53	1.42
79	Ovarian cancer	Enrichment	TP53	1.36
80	Inherited cancer-predisposing syndrome	Enrichment	TP53	1.24

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

MicroRNA network associated with chronic lymphocytic leukemia

Pathway Network for MicroRNA network associated with chronic lymphocytic leukemia

Member Pathways for MicroRNA network associated with chronic lymphocytic leukemia

Pathways in the MicroRNA network associated with chronic lymphocytic leukemia SuperPath

Associated Genes for MicroRNA network associated with chronic lymphocytic leukemia

Associated Disorders for MicroRNA network associated with chronic lymphocytic leukemia

Disorders associated with MicroRNA network associated with chronic lymphocytic leukemia SuperPath

STRING Interaction Network for MicroRNA network associated with chronic lymphocytic leukemia

Sources for MicroRNA network associated with chronic lymphocytic leukemia